Skip to main content

Published locations for Alemtuzumab Reduces Minimal Residual Disease in CLL Patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alemtuzumab Reduces Minimal Residual Disease in CLL Patients

User login

  • Reset your password
  • /content/alemtuzumab-reduces-minimal-residual-disease-cll-patients
  • /internalmedicinenews/article/19812/oncology/alemtuzumab-reduces-minimal-residual-disease-cll
  • /internalmedicine/article/19812/oncology/alemtuzumab-reduces-minimal-residual-disease-cll-patients